Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(8)
Dna Methyltransferase
Immunohistochemi...
Malignant Glioma
Overall Survival
Polymerase Chain Reaction
Protein Expression
Statistical Significance
Progression Free Survival
Subscribe
Academic
Publications
Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas
Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas,10
Edit
Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas
(
Citations: 2
)
BibTex
|
RIS
|
RefWorks
Download
Francesca R. Buttarelli
,
Maura Massimino
,
Libero Lauriola
,
Paolo Nozza
,
Vittoria Donofrio
,
Antonella Arcella
,
Maria A. Oliva
,
Concezio Di Rocco
,
Felice Giangaspero
Introduction In this study, we investigated the prognostic and predictive value of MGMT promoter methylation and
protein expression
in 30 pediatric high grade gliomas (pHGG). Methods MGMT promoter methylation was assayed by methylation-specific
polymerase chain reaction
(MSP), whereas MGMT
protein expression
was evaluated by
immunohistochemistry
(IHC). Results MGMT promoter methylation was observed in 7/24 (30%) cases, whereas MGMT protein overexpression was found in 19/28 (68%) cases with similar distribution in grade III and grade IV gliomas. Median survival of methylated and unmethylated patients was 16 and 8 months, respectively. Moreover,
overall survival
and progression-free survival showed a trend toward reduction in patients with unmethylation (p = 0.9 and p = 0.7, respectively). For MGMT protein expression, the median survival was 8.5 and 17 months for patients with MGMT overexpression or low expression, respectively. Although these two groups did not show statistically significant differences in terms of
overall survival
or progression-free survival (p = 0.8 and p = 0.7, respectively), there was a significant correlation between MGMT
protein expression
and MGMT promoter methylation status (p = 0.01). Conclusions Our findings indicate that, in pHGG, (a) MGMT promoter methylation is less frequent than in adult malignant gliomas, (b) there is a high correlation between MGMT MSP and MGMT IHC, and (c) as in adults, MGMT status is associated with prognosis, although this observation has to be statistically validated on larger series of patients.
Journal:
Childs Nervous System - CHILD NERV SYST
, vol. 26, no. 8, pp. 1051-1056, 2010
DOI:
10.1007/s00381-010-1191-1
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.springerlink.com
)
(
www.springerlink.com
)
(
www.springerlink.com
)
(
www.springerlink.com
)
More »
Citation Context
(2)
...We read with great interest the recent articles of Buttarelli et al. [
1
] and Srivastava et al. [2 ]o nMGMT status in pediatric high-grade gliomas...
Matteo Fassan
,
et al.
MGMT promoter methylation in pediatric high-grade gliomas
...However, two of the three studies were either based on results from immunohistochemistry [2] or included groups with grade III gliomas [2,
15
]...
...Donson et al. [14] 10 10.4 (3–20.8) MSP 40 Statistically significant correlation Buttarelli et al. [
15
] 18 9.8 (0.6–17) MSP and IHC 45 Suggested...
Ji Yeoun Lee
,
et al.
MGMT promoter gene methylation in pediatric glioblastoma: analysis usi...
References
(16)
Population-based epidemiologic data on brain tumors in German children
(
Citations: 75
)
Peter Kaatsch
,
Christian H. Rickert
Journal:
Cancer
, vol. 92, no. 12, pp. 3155-3164, 2001
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
(
Citations: 606
)
Monika E. Hegi
,
Annie-Claire Diserens
,
Thierry Gorlia
,
Marie-France Hamou
,
Nicolas de Tribolet
,
Michael Weller
,
Johan M. Kros
,
Johannes A. Hainfellner
,
Warren Mason
,
Luigi Mariani
,
Jacoline E. C. Bromberg
,
Peter Hau
http://academic.research.microsoft.com/io.ashx?type=5&id=5754317&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
New England Journal of Medicine - N ENGL J MED
, vol. 352, no. 10, pp. 997-1003, 2005
Temozolomide in malignant gliomas: current use and future targets
(
Citations: 17
)
J. Lee Villano
,
Tara E. Seery
,
Linda R. Bressler
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 64, no. 4, pp. 647-655, 2009
Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas
(
Citations: 60
)
M. Brell
Journal:
Clinical Cancer Research - CLIN CANCER RES
, vol. 11, no. 14, pp. 5167-5174, 2005
Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastoma Patients Treated with Temozolomide
(
Citations: 170
)
M. E. Hegi
Journal:
Clinical Cancer Research - CLIN CANCER RES
, vol. 10, no. 6, pp. 1871-1874, 2004
Sort by:
Citations
(2)
MGMT promoter methylation in pediatric high-grade gliomas
Matteo Fassan
,
Evelyne Tassone
,
Maurizio Onisto
,
Giorgio Perilongo
,
Domenico D’Avella
,
Marina Paola Gardiman
Journal:
Childs Nervous System - CHILD NERV SYST
, vol. 27, no. 1, pp. 7-8, 2011
MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA
Ji Yeoun Lee
,
Chul-Kee Park
,
Sung-Hye Park
,
Kyu-Chang Wang
,
Byung-Kyu Cho
,
Seung-Ki Kim
Journal:
Childs Nervous System - CHILD NERV SYST
, pp. 1-7